Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Magnuson

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Science Immunology|November 18, 2022
OXPHOS promotes apoptotic resistance and cellular persistence in T<sub>H</sub>17 cells in the periphery and tumor microenvironmentHanna S Hong, Nneka E Mbah, Mengrou Shan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
Nature Communications|October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
Nature|April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Nature Communications|August 12, 2021
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosisDaniel M Kremer, Barbara S Nelson, Lin Lin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Science Immunology|November 18, 2022
OXPHOS promotes apoptotic resistance and cellular persistence in T<sub>H</sub>17 cells in the periphery and tumor microenvironmentHanna S Hong, Nneka E Mbah, Mengrou Shan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
Nature Communications|October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
Nature|April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Nature Communications|August 12, 2021
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosisDaniel M Kremer, Barbara S Nelson, Lin Lin, et al.
Pageof 5